Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,032,584
in 16 filings, $9.5M under 10b5-1 plans

Net −$17,032,584. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-28 Schundler Russell General Counsel Exercise or conversion · Restricted Stock Units 10b5-1 −2,343 2,344
2025-11-28 Kaseta Michael CFO and COO Exercise or conversion 10b5-1 +2,343 354,989
2025-11-28 Kaseta Michael CFO and COO Exercise or conversion · Restricted Stock Units 10b5-1 −2,343 2,344
2025-11-28 Adair Jason Chief Business Officer Exercise or conversion 10b5-1 +1,563 176,561
2025-11-28 Adair Jason Chief Business Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,563 1,562
2025-11-28 Moomaw Scott Chief Commercial Officer Exercise or conversion 10b5-1 +1,875 155,337
2025-11-28 Moomaw Scott Chief Commercial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,875 1,875
2025-11-18 Adair Jason Chief Business Officer Exercise or conversion 10b5-1 +35,291 $5.89 $208K 210,289
2025-11-18 Adair Jason Chief Business Officer Exercise or conversion 10b5-1 +365 $5.89 $2K 210,654
2025-11-18 Adair Jason Chief Business Officer Sale 10b5-1 −35,656 $30.03 $1.1M 174,998
2025-11-18 Adair Jason Chief Business Officer Exercise or conversion · Incentive Stock Option (right to buy) 10b5-1 −35,291 0
2025-11-18 Adair Jason Chief Business Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 −365 0
2025-11-07 Boyle Dana Chief Accounting Officer Sale −8,342 $25.16 $210K 175,996
2025-11-07 Boyle Dana Chief Accounting Officer Sale −20,662 $25.06 $518K 155,334
2025-11-05 Saggar Rajeev Chief Medical Officer Sale −4,918 $27.00 $133K 243,012
2025-11-05 Saggar Rajeev Chief Medical Officer Sale −66,463 $27.00 $1.8M 176,549
2025-10-27 Adair Jason Chief Business Officer Sale 10b5-1 −692 $22.93 $16K 174,998
2025-10-27 Boyle Dana Chief Accounting Officer Sale 10b5-1 −1,073 $22.93 $25K 184,338
2025-10-13 Schundler Russell General Counsel Sale 10b5-1 −7,839 $23.41 $184K 576,017
2025-10-13 Kaseta Michael CFO and COO Sale 10b5-1 −11,630 $23.41 $272K 352,646

Page 20 of 29 · 579 trades